Physician profile
Christine Anne Tagayun
NPI 1952747289
$21,036.37
in general payments reported to CMS, 2019-2025
27 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $288 · 2021: $1,666 · 2022: $1,025 · 2023: $3,193 · 2024: $2,814 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,088 · Travel and Lodging: $4,737 · Food and Beverage: $4,268 · Honoraria: $1,400 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,087.50 |
| Travel and Lodging | $4,737.37 |
| Food and Beverage | $4,268.46 |
| Honoraria | $1,400.00 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $11,083.09 | 2021-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Idosetr |
| Alcon Vision LLC | $2,214.39 | 2019-2025 | Lensx, Clareon, Tryptyr |
| Johnson & Johnson Surgical Vision, INC. | $1,858.29 | 2021-2024 | Star S4 Ir, Veritas Vision System, Tecnis Iol |
| Harrow Eye, LLC | $1,761.77 | 2024-2025 | Vevye |
| Abbvie INC. | $1,384.55 | 2022-2024 | Lumigan, Vuity, Durysta |
| Dompe US, INC. | $469.27 | 2019-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $315.96 | 2022-2025 | Xiidra, Miebo, Alden Scleral Zenlens |
| Sun Pharmaceutical Industries INC. | $314.21 | 2021-2024 | Cequa |
| Kala Pharmaceuticals, INC. | $285.91 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $201.11 | 2020-2023 | |
| Allergan, INC. | $170.02 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $132.60 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $125.00 | 2019 | |
| Biotissue Holdings INC. | $113.73 | 2024-2025 | |
| Astellas Pharma US INC | $104.73 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $95.09 | 2019-2021 | |
| Rxsight INC | $65.63 | 2023-2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Sight Sciences, INC. | $60.97 | 2021-2023 | Sion Surgical Instrument, Omni Surgical System |
| New World Medical,INC. | $58.90 | 2023 | |
| Oyster Point Pharma, INC. | $45.05 | 2022-2024 | Tyrvaya |
| Omeros Corporation | $36.76 | 2019-2020 | |
| Horizon Therapeutics Plc | $32.85 | 2022-2023 | Tepezza |
| Amgen INC. | $28.48 | 2025 | Tepezza |
| Genzyme Corporation | $27.76 | 2023 | |
| Ocular Therapeutix, INC. | $21.41 | 2021 | |
| Rayner Intraocular Lenses Limited | $15.15 | 2022 | |
| Eyevance Pharmaceuticals LLC | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Tagayun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.